Comparing treatments for Trigger Finger using shock wave therapy and splints
Effectiveness of Conservative Interventions in the Treatment of Trigger Finger
This study is testing whether shock wave therapy alone, shock wave therapy with splints, or just splints works best to relieve pain and improve function for people with Trigger Finger.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 54 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara, Ankara) |
| Trial ID | NCT06296017 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of two conservative treatments for Trigger Finger: Extracorporeal Shock Wave Therapy (ESWT) and splint therapy. Patients diagnosed with stage 1 or stage 2 Trigger Finger will be randomly assigned to one of three groups: one receiving ESWT, another receiving ESWT combined with splint therapy, and a third receiving only splint therapy. The treatment's effectiveness will be evaluated through pain assessments and functional measurements at multiple time points. The study aims to provide evidence on the best conservative treatment approach for this condition.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 diagnosed with stage 1 or stage 2 Trigger Finger.
Not a fit: Patients with inflammatory disorders, previous hand/wrist surgeries, or neurological diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with more effective treatment options for Trigger Finger, potentially reducing pain and improving hand function.
How similar studies have performed: While there is limited literature directly comparing ESWT and splint therapy for Trigger Finger, similar conservative treatment approaches have shown promise in other musculoskeletal conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteering * Being between the ages of 18-65 * Being diagnosed with stage 1 or stage 2 (according to the Froimson classification) trigger finger * Having the language and cognitive skills to answer the questionnaires used in the evaluation Exclusion Criteria: * Being pregnant * Having an inflammatory disorder * Having had surgery on the hand/wrist * Having a neurological disease * NSAIDs, painkillers, etc. being on medication * De Quervain's tenosynovitis, carpal tunnel syndrome
Where this trial is running
Ankara, Ankara
- Feray Karademir — Ankara, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Feray Karademir
- Email: karademirferay@gmail.com
- Phone: +90 505 313 75 82
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.